Mosha Deng
President
Mosha is currently conducting Bioengineering research focused on engineering next generation CAR-T cells for solid tumors and other diseases. Prior to Penn, Mosha led business development & licensing activities at Insmed, a biotechnology firm focused on rare diseases, and advised healthcare clients on M&A and financing matters at UBS Investment Bank.